Study reveals how herpes virus tricks the immune system
Scientists have captured atomic images of the virus that causes cold sores in action. Structural details reveal that the virus inserts itself into another protein, jamming an important immune system pathway that normally allows immune cells to recognize and destroy foreign invaders. More » (Source: The Rockefeller University Newswire)
Source: The Rockefeller University Newswire - February 3, 2016 Category: Biomedical Science Authors: pubaff Tags: Science News Source Type: news
Study reveals how herpes virus tricks the immune system
(Rockefeller University) Scientists have captured atomic images of the virus that causes cold sores in action. Structural details reveal that the virus inserts itself into another protein, jamming an important immune system pathway that normally allows immune cells to recognize and destroy foreign invaders. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 3, 2016 Category: Infectious Diseases Source Type: news
More and More OR Pubs
Potent, Proven and Frequently PublishedMany labs have used our Opioid Receptor antibodies over the past 10+ years. We are grateful for the many publications and testimonals referencing successful use of these antibodies.Here's a sampling of more recent publications: Wendy M. Walwyn, Wenling Chen, Hyeyoung Kim, Ani Minasyan, Helena S. Ennes, James A. McRoberts, and Juan Carlos G. Marvizón. Sustained Suppression of Hyperalgesia during Latent Sensitization by μ-, δ-, and κ-opioid receptors and α2A Adrenergic Receptors: Role of Constitutive Activity. The Journal of Neuroscience, 6 January 2016, 36(1): 204-221; d...
Source: Neuromics - January 25, 2016 Category: Neuroscience Tags: DOR Antibody Kappa Opioid Receptor Antibodies KOR Antibody MOR Antibody Mu Opioid Receptor antibody Opioid Receptors Antibodies Source Type: news
The Real Reason You Get Sick After A Stressful Period Has Ended
Have you ever wondered how you manage to get through a particularly stressful period – whether it's an intense deadline at work, final exams in school or a spate of holiday houseguests – only to get sick after the stress has lifted?
It's not a fluke. It's a phenomenon that's often referred to as "the let-down effect," a pattern in which people come down with an illness or develop flare-ups of a chronic condition not during a concentrated period of stress but after it dissipates, explains psychologist Marc Schoen, an assistant clinical professor of medicine at the Universi...
Source: Healthy Living - The Huffington Post - January 24, 2016 Category: Consumer Health News Source Type: news
[Editors' Choice] How stress can overcome latency
JNK signaling alters chromatin to induce reactivation of latent herpes simplex virus. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - December 23, 2015 Category: Science Authors: Nancy Gough (mailto:ngough at aaas.org) Source Type: news
Life-prolonging jab made from the HERPES virus 'cures skin cancer'
The jab, is made from a genetically engineered form of the herpes virus, which causes cold sores. It was approved by the European Medicines Agency watchdog today for use in the UK. (Source: the Mail online | Health)
Source: the Mail online | Health - December 18, 2015 Category: Consumer Health News Source Type: news
Life-prolonging jab made from the HERPES virus 'cures aggressive skin cancer' - offering hope to thousands
The jab, is made from a genetically engineered form of the herpes virus, which causes cold sores. It was approved by the European Medicines Agency watchdog today for use in the UK. (Source: the Mail online | Health)
Source: the Mail online | Health - December 18, 2015 Category: Consumer Health News Source Type: news
European Commission approves Amgen’s IMLYGIC as first oncolytic immunotherapy in Europe
IMLYGIC is approved in the European Union specifically for early stage metastatic patients (Source: Pharmacy Europe)
Source: Pharmacy Europe - December 18, 2015 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Practical therapeutics Oncology early stage metastic patients herpes simplex type 1 virus IMLYGIC immunotherapy Latest News melanoma Source Type: news
Medical News Today: How the herpes virus reactivates under stress
People with the herpes simplex virus often experience cold sores when under stress. Researchers have now found a mechanism that appears to explain this. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 10, 2015 Category: Consumer Health News Tags: Infectious Diseases / Bacteria / Viruses Source Type: news
Discovery shows how herpes simplex virus reactivates in neurons to trigger disease
(University of North Carolina Health Care) When we get cold sores, the reason is likely related to stress. For the first time, researchers discovered a cellular mechanism that allows the herpes simplex virus to reactivate. They also found how brain cells are duped into allowing this to happen so that the virus can cause disease. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 9, 2015 Category: Infectious Diseases Source Type: news
Imlygic (talimogene laherparepvec) for the Treatment of Cutaneous, Subcutaneous and Nodal Lesions
Developed by Amgen, Imlygic (talimogene laherparepvec) is the first injectable formulation of altered herpes simplex virus type 1 for the treatment of cutaneous, subcutaneous and nodal lesions in patients with melanoma recurrence after initial surger… (Source: Drug Development Technology)
Source: Drug Development Technology - December 7, 2015 Category: Pharmaceuticals Source Type: news
EXCLUSIVE: Cold sores are KEY to destroying cancer tumours
A PIONEERING British cancer jab that uses the cold sore virus to destroy tumours is expected to be available on the NHS within months. (Source: Daily Express - Health)
Source: Daily Express - Health - November 30, 2015 Category: Consumer Health News Source Type: news
Population Council's MZC outperforms TFV 1 percent gel in microbicide candidate preclinical study
(Population Council) New data from a preclinical safety and efficacy study of the candidate microbicide gel MZC, which targets HIV, herpes simplex virus and human papillomavirus, shows that the gel performs as well as, or in many cases, better than, tenofovir 1 percent gel, a leading microbicide candidate. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 25, 2015 Category: Infectious Diseases Source Type: news
Everything You Think You Know About Herpes Is Wrong
By Kristine Thomason Hate to break it to you, but you probably have herpes. Turns out, nearly two-thirds of the global population is infected with herpes simplex virus type 1 (HSV-1), according to a recent report released by the World Health Organization (WHO). The WHO researchers estimated that 3.7 billion people under the age of 50 are infected with HSV-1, which is best known as a cause of cold sores. Another 417 million people worldwide aged 15-49 have HSV-2, the type most often thought of as a sexually transmitted disease. But get this-140 million adults have genital infections caused by HSV-1, meaning half a billio...
Source: Healthy Living - The Huffington Post - November 16, 2015 Category: Consumer Health News Source Type: news
66% of World Population Under 50 Infected with Herpes Simplex Virus Type 1
More than 3.7 billion people under the age of 50 - or 67% of the population - are infected with herpes simplex virus type 1 (HSV-1), according to WHO’s first global estimates of HSV-1 infection published today in the journal PLOS ONE. (Source: Disabled World)
Source: Disabled World - October 31, 2015 Category: Disability Tags: Herpes Simplex Virus Source Type: news
